Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis.

导出 OA

翻译打印收藏纠错

作者： Sophie,Bustany ^[1] ; Julie,Cahu ^[2] ; Géraldine,Descamps ^[3] ; Catherine,Pellat-Deceunynck ^[4] ; Brigitte,Sola ^[5]

作者单位： Normandie Univ, UNICAEN, EA4652, Caen, France. sophie.bustany@ch-flers.fr. ^[1] Normandie Univ, UNICAEN, EA4652, Caen, France. julie.cahu@gmail.com. ^[2] CRCNA, INSERM U892, CNRS UMR6299, Université de Nantes, Nantes, France. geraldine.descamps@univ-nantes.fr. ^[3] CRCNA, INSERM U892, CNRS UMR6299, Université de Nantes, Nantes, France. catherine.pellat-deceunynck@inserm.fr. ^[4] Normandie Univ, UNICAEN, EA4652, Caen, France. brigitte.sola@unicaen.fr. ^[5]

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);二苯甲基化合物(Benzhydryl Compounds);印迹法, 蛋白质(Blotting, Western);细胞系, 肿瘤(Cell Line, Tumor);细胞, 培养的(Cells, Cultured);DNA结合蛋白质类(DNA-Binding Proteins);人类(Humans);多发性骨髓瘤(Multiple Myeloma);吡咯烷酮类(Pyrrolidinones);转录因子(Transcription Factors)

DOI 10.1186/s13045-015-0135-3

PMID 25898974

发布时间 2018-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览20

Journal of hematology & oncology

2015年8卷

40页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis.

Journal of hematology & oncology

相似文献

Journal of hematology & oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis.

Journal of hematology & oncology

相似文献

Journal of hematology & oncology

相关期刊

检索历史清除